C79.7
Secondary malignant neoplasm of adrenal gland
Clinical Classification Guidelines
Medical Intelligence & Overview
Secondary malignant neoplasm of the adrenal gland, classified under ICD-10 code C79.7, refers to cancer that has spread (metastasized) to the adrenal glands from a primary tumor located elsewhere in the body. The adrenal glands are small, triangular-shaped glands situated on top of each kidney. They play a vital role in hormone production, including adrenaline and cortisol. When cancer cells from another part of the body reach the adrenal glands, they can grow and interfere with normal gland function, often indicating advanced or spreading cancer. Diagnosing and understanding secondary adrenal tumors is crucial for managing the overall cancer treatment plan.
Causes & Symptoms
Clinical Causes: Spread of primary cancers, such as lung, breast, melanoma, or gastrointestinal tumors, to the adrenal glands. Metastasis often occurs via bloodstream or lymphatic system, allowing cancer cells to reach the adrenal tissue. Some primary cancers are more prone to metastasize to the adrenal glands due to blood flow patterns or tissue affinity.
Key Symptoms: Often no noticeable symptoms in early stages. Potential signs may include abdominal or flank pain. Unexplained weight loss and general fatigue. Hormonal symptoms if the tumor affects adrenal function, such as high blood pressure, irregular heartbeat, or excessive sweating. Additional symptoms depend on the primary cancer and extent of metastasis.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of imaging studies and laboratory tests. Common methods include:
Treatment Protocols: Treatment strategies depend on the primary cancer, extent of metastasis, and overall health of the patient. Approaches may include:
Clinical Advice & FAQs
Billing Guidance
Is C79.7 a billable ICD-10 code?
Yes, C79.7 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C79.7?
Clinical documentation must specify the nature of Secondary malignant neoplasm of adrenal gland and any associated comorbidities for accurate reporting.
Cite this Clinical Reference